Manoj Chelvanambi

14PUBLICATIONS
170CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Exercise physiologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 04, 2026
Neoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial.

|Nov 14, 2025
Microbial signals in primary and metastatic brain tumors.

Golnaz Morad, Ashish V Damania, Brenda Melendez

|Aug 01, 2025
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities.

Anne Knisely, Yibo Dai, Graham L Barlow

|Jul 03, 2025
PPP2R1A mutations portend improved survival after cancer immunotherapy.

Yibo Dai, Anne Knisely, Mitsutake Yano

|Feb 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.

Christina L Roland, Elise F Nassif Haddad, Emily Z Keung

|Sep 19, 2023
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome.

Nan Deng, Laura Reyes-Uribe, Johannes F Fahrmann

Pageof 3

Frequent Collaborators

11 joint publications

Jennifer A Wargo

8 joint publications

Alexander J Lazar

5 joint publications

Shannon N Westin

5 joint publications

Linghua Wang